Works matching IS 14611457 AND DT 2012 AND VI 15 AND IP 4

Results: 24

Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 449, doi. 10.1017/S1461145711000745
By:
- Konstantinidis, A.;
- Papageorgiou, K.;
- Grohmann, R.;
- Horvath, A.;
- Engel, R.;
- Kasper, S.
Publication type:
Article
Neuron density and serotonin receptor binding in prefrontal cortex in suicide.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 435, doi. 10.1017/S1461145711000691
By:
- Underwood, Mark D.;
- Kassir, Suham A.;
- Bakalian, Mihran J.;
- Galfalvy, Hanga;
- Mann, J. John;
- Arango, Victoria
Publication type:
Article
D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson’s disease.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 543, doi. 10.1017/S1461145711001015
By:
- Gelfin, Evgenia;
- Kaufman, Yakir;
- Korn-Lubetzki, Isabelle;
- Bloch, Boaz;
- Kremer, Ilana;
- Javitt, Daniel C.;
- Heresco-Levy, Uriel
Publication type:
Article
Vagus nerve stimulation enhances perforant path-CA3 synaptic transmission via the activation of β-adrenergic receptors and the locus coeruleus.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 523, doi. 10.1017/S1461145711000708
By:
- Huilian Shen;
- Yuta Fuchino;
- Daisuke Miyamoto;
- Hiroshi Nomura;
- Norio Matsuki
Publication type:
Article
Cerebroside-A provides potent neuroprotection after cerebral ischaemia through reducing glutamate release and Ca2+ influx of NMDA receptors.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 497, doi. 10.1017/S1461145711000654
By:
- Lin Li;
- Rong Yang;
- Kaiyue Sun;
- Yinyang Bai;
- Zhuo Zhang;
- Libin Zhou;
- Zhi Qi;
- Jianhua Qi;
- Ling Chen
Publication type:
Article
Dopamine in the hippocampus is cleared by the norepinephrine transporter.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 531, doi. 10.1017/S1461145711000812
By:
- Borgkvist, Anders;
- Malmlöf, Torun;
- Feltmann, Kristin;
- Lindskog, Maria;
- Schilström, Björn
Publication type:
Article
DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 459, doi. 10.1017/S1461145711000903
By:
- Alkelai, Anna;
- Lupoli, Sara;
- Greenbaum, Lior;
- Kohn, Yoav;
- Kanyas-Sarner, Kyra;
- Ben-Asher, Edna;
- Lancet, Doron;
- Macciardi, Fabio;
- Lerer, Bernard
Publication type:
Article
Modulation of haloperidol-induced patterns of the transcription factor Nur77 and Nor-1 expression by serotonergic and adrenergic drugs in the mouse brain.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 509, doi. 10.1017/S1461145711000630
By:
- Maheux, Jérôme;
- Vuillier, Laura;
- Mahfouz, Mylène;
- Rouillard, Claude;
- Lévesque, Daniel
Publication type:
Article
Opposing effects of 5,7-DHT lesions to the core and shell of the nucleus accumbens on the processing of irrelevant stimuli.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 485, doi. 10.1017/S1461145711000599
By:
- Nelson, Andrew J. D.;
- Thur, Karen E.;
- Marsden, Charles A.;
- Cassaday, Helen J.
Publication type:
Article
Blockade of dopamine D3 but not D2 receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 471, doi. 10.1017/S1461145711000435
By:
- Watson, David J. G.;
- Marsden, Charles A.;
- Millan, Mark J.;
- Fone, Kevin C. F.
Publication type:
Article
An enhancement of the firing activity of dopamine neurons as a common denominator of antidepressant treatments?
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 551, doi. 10.1017/S1461145711001362
By:
- Chenu, Franck;
- Ghanbari, Ramez;
- El Mansari, Mostafa;
- Blier, Pierre
Publication type:
Article
mTOR activation is required for the antidepressant effects of mGluR2/3 blockade.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 429, doi. 10.1017/S1461145711001702
By:
- Dwyer, Jason M.;
- Lepack, Ashley E.;
- Duman, Ronald S.
Publication type:
Article
PNP volume 15 issue 5 Cover and Back matter.
Published in:
2012
Publication type:
Table of Contents
PNP volume 15 issue 5 Cover and Front matter.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. f1, doi. 10.1017/S1461145712000430
Publication type:
Article
Auditory event-related potentials (P3) and cognitive changes induced by frontal direct current stimulation in alcoholics according to Lesch alcoholism typology.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 601, doi. 10.1017/S1461145711001040
By:
- Nakamura-Palacios, Ester Miyuki;
- de Almeida Benevides, Marcelo Campos;
- da Penha Zago-Gomes, Maria;
- de Oliveira, Roney Welinton Dias;
- de Vasconcellos, Vítor Fiorin;
- de Castro, Lais Norberto Passos;
- da Silva, Morgana Croce;
- Ramos, Paula Amorim;
- Fregni, Felipe
Publication type:
Article
A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 589, doi. 10.1017/S1461145711001027
By:
- Alvarez, Enric;
- Perez, Victor;
- Dragheim, Marianne;
- Loft, Henrik;
- Artigas, Francesc
Publication type:
Article
Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 669, doi. 10.1017/S1461145711000940
By:
- Melas, Philippe A.;
- Rogdaki, Maria;
- Lennartsson, Andreas;
- Björk, Karl;
- Qi, Hongshi;
- Witasp, Anna;
- Werme, Martin;
- Wegener, Gregers;
- Mathé, Aleksander A.;
- Svenningsson, Per;
- Lavebratt, Catharina
Publication type:
Article
Rapid-acting antidepressant strategies: mechanisms of action.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 695, doi. 10.1017/S1461145711000927
By:
- Bunney, Blynn G.;
- Bunney, William E.
Publication type:
Article
Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 573, doi. 10.1017/S1461145711000861
By:
- Gil-Pisa, Itziar;
- Munarriz-Cuezva, Eva;
- Ramos-Miguel, Alfredo;
- Urigüen, Leyre;
- Meana, J. Javier;
- García-Sevilla, Jesús A.
Publication type:
Article
Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 657, doi. 10.1017/S1461145711000848
By:
- Jones, Nigel C.;
- Reddy, Maya;
- Anderson, Paul;
- Salzberg, Michael R.;
- O'Brien, Terence J.;
- Pinault, Didier
Publication type:
Article
Slow dissociation of partial agonists from the D2 receptor is linked to reduced prolactin release.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 645, doi. 10.1017/S1461145711000824
By:
- Carboni, Lucia;
- Negri, Michele;
- Michielin, Francesca;
- Bertani, Simone;
- Fratte, Sonia Delle;
- Oliosi, Beatrice;
- Cavanni, Paolo
Publication type:
Article
Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT4 receptor agonist RS67333.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 631, doi. 10.1017/S1461145711000782
By:
- Pascual-Brazo, Jesús;
- Castro, Elena;
- Díaz, Álvaro;
- Valdizán, Elsa M.;
- Pilar-Cuéllar, Fuencisla;
- Vidal, Rebeca;
- Treceño, Begoña;
- Pazos, Ángel
Publication type:
Article
Mood dysregulation and stabilization: perspectives from emotional cognitive neuroscience.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 681, doi. 10.1017/S1461145711000757
By:
- Yamawaki, Shigeto;
- Okada, Go;
- Okamoto, Yasumasa;
- Liberzon, Israel
Publication type:
Article
Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α2-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.
Published in:
International Journal of Neuropsychopharmacology, 2012, v. 15, n. 4, p. 617, doi. 10.1017/S1461145711000733
By:
- Serres, Florence;
- Millan, Mark J.;
- Sharp, Trevor
Publication type:
Article

Works matching IS 14611457 AND DT 2012 AND VI 15 AND IP 4

Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program.

Neuron density and serotonin receptor binding in prefrontal cortex in suicide.

D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson’s disease.

Vagus nerve stimulation enhances perforant path-CA3 synaptic transmission via the activation of β-adrenergic receptors and the locus coeruleus.

Cerebroside-A provides potent neuroprotection after cerebral ischaemia through reducing glutamate release and Ca<sup>2+</sup> influx of NMDA receptors.

Dopamine in the hippocampus is cleared by the norepinephrine transporter.

DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population.

Modulation of haloperidol-induced patterns of the transcription factor Nur77 and Nor-1 expression by serotonergic and adrenergic drugs in the mouse brain.

Opposing effects of 5,7-DHT lesions to the core and shell of the nucleus accumbens on the processing of irrelevant stimuli.

Blockade of dopamine D<sub>3</sub> but not D<sub>2</sub> receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment.

An enhancement of the firing activity of dopamine neurons as a common denominator of antidepressant treatments?

mTOR activation is required for the antidepressant effects of mGluR<sub>2/3</sub> blockade.

PNP volume 15 issue 5 Cover and Back matter.

PNP volume 15 issue 5 Cover and Front matter.

Auditory event-related potentials (P3) and cognitive changes induced by frontal direct current stimulation in alcoholics according to Lesch alcoholism typology.

A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder.

Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression.

Rapid-acting antidepressant strategies: mechanisms of action.

Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment.

Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power.

Slow dissociation of partial agonists from the D2 receptor is linked to reduced prolactin release.

Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT4 receptor agonist RS67333.

Mood dysregulation and stabilization: perspectives from emotional cognitive neuroscience.

Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α2-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.